Calls for Proposals FY 2022 Awarded PMs under Moonshot Research and Development Program (3rd Proposal)

Outline

Status of Grants/Funding Opportunities Awarded projects
R&D phase Basic Study, Applied Study, Nonclinical Study/Pre-clinical Study, Clinical Study, Clinical Trials, None
Key Fields Moonshot Research and Development Program, Cancer
Contact
Office of Project Management
-Division of Moonshot Research and Development Program
E-mail: moonshot"AT"amed.go.jp , Replace "AT" with "@"
Remarks:
※Please specify the title of e-mail with “Inquiry for the 3rd proposal”
※Please replace “AT” with “@” in the e-mail address.
※Your inquiries will be accepted only by e-mail. Please contact the address above.

Adoption contents

Regarding FY2022 the Public Offering for the 3rd Proposal of Moonshot Research and Development Program (solicitation period 2022.3.7 – 2022.5.10), Japan Agency for Medical Research and Development (AMED) conducted strict and fair deliberation by the evaluation committee (PDF). And as a result of the evaluation, AMED decided project managers to adopt for the projects as follows:

Research and Development Project PM Affiliation Position
Actualization of a cancer-free society through regulation of chronic inflammation NISHIKAWA Hiroyoshi Nagoya University Professor
A world of zero cancer risk created by rejuvenation using cell lineage conversion KOSEKI Haruhiko RIKEN Deputy Center Director

Evaluation Process

Solicitation Period 2022.3.7 Mon – 2022.5.10 Tue
Evaluation committee 2022.7.28 Thu
Number of applicants recieved 11
Number of proposals interviewed 3
Number of proposals selected for funding 2

Links

09/30/22

Last updated 09/30/22